Insights / Therapeutic Area
Field notes on Inflammation and Immunology — the therapeutic frontier where biologics, small molecules, and cell therapies converge.
2 posts in Inflammation / Immunology
1 Sept 2026 · 2 min read
Sword Health is acquiring Headspace for a reported $200 million to $300 million, roughly 90 percent below its $3 billion 2021 valuation. I see this consolidation as the start of digital health's mature days.
19 Feb 2026 · 2 min read
Two pharma-AI deals in two weeks, two completely different architectures. Takeda paid $1.7B for Iambic. Now Merck skips techbio entirely and runs its AI models inside Mayo Clinic’s secure data environment. The architecture behind the Merck deal is what matters.